menu

Quintiles Library

Show Filters
Presentation
In the past 5 years, our medical communications team has delivered over 250 meetings to 13,500 delegates.
Explore more
White Paper
Many excellent reviews have already detailed the industry’s declining R&D productivity, increasing development costs, decreasing pipeline and lower earnings. Many more highlight prominent initiatives to bolster pipelines and cut costs. However, there is also something new percolating within biopharma companies — a growing sense that traditional cost-cutting and...
Explore here
Press Release
RESEARCH TRIANGLE PARK, N.C. – May 26, 2009 – Today, Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announced the availability of two new laboratory tests used to develop more effective cancer treatments. These new tests are now being used in the clinical development of targeted therapies more likely to succeed in treating patients with cancer...
Read More
Fact Sheet
Every year Quintiles attends several Career Fairs in the Netherlands. See this years list
Read more
Press Release
RESEARCH TRIANGLE PARK, N.C. – April 28, 2009 – Quintiles Consulting today announced the appointment of James Kirk as Practice Leader for Eidetics, the Market Intelligence and Analytics Practice of Quintiles Consulting. Quintiles Consulting’s decision analytics group, Eidetics, provides analytics-based strategic research and consulting support to major biopharma...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – April 23, 2009 – Quintiles was named by industry decision-makers as the most favored contract research organization (CRO), according to two recently released independent surveys. Quintiles ranked number one across a range of service and reputation attributes, from breadth of service through to therapeutic expertise. Results from the fourth...
Read More
Fact Sheet
Quintiles benefit risk analysis can help you anticipate potential regulatory concerns and highlight the benefit side of your drug’s benefit risk profile.
Read more
Fact Sheet
New, more efficient delivery models help meet the increasing demands of Phase IIIB/IV Studies.
Read more
Press Release
RESEARCH TRIANGLE PARK, N.C. – April 15, 2009 -- Quintiles has been recognized by the Great Place to Work® (GPTW) Institute Canada as one of the top 25 companies to work for in the country. It is the first time Quintiles has made the Canadian GPTW list since the Institute’s awards were launched there in 2005. Quintiles is the world’s largest pharmaceutical services...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – April 7, 2009 – Quintiles Transnational Corp. today announced the appointment of Richard (Rich) Pilnik to serve as President, Innovex – a Quintiles company that helps pharmaceutical and biotech companies maximize commercial success across a product’s lifecycle. Pilnik has 25 years of experience in the pharmaceutical commercial sector, most...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – April 2, 2009 – Quintiles Transnational Corp. today announced the achievement of another industry-leading milestone – its 400th clinical trial using Electronic Data Capture (EDC). In addition to starting its 400th EDC trial, Quintiles has locked databases – the final step in data capture -- on more than 270 EDC trials since 2000. To date,...
Read More
Case Study
In a randomized, double-blind, active-controlled study of Drug X for the treatment of anemia in subjects with non-myeloid malignancy receiving multi-cycle chemotherapy, Quintiles carried out a feasibility study and chose the sites where the patients would be easy to find. Quintiles Study Site Coordinators helped investigators prescreen the patients so that as soon as the...
Read more
Presentation
This presentation was given by Mir Imran Ali, M.Pharma, M.B.A., CCDM, PMP at DIA India in March 2009. See the rest of the presentation.
Explore more
White Paper
It is no exaggeration to say that electronic data capture (EDC) is a practice of the new millennium; the introduction of technology into the collection and cleaning of clinical trial data has gained real momentum since 2000. Quintiles has embarked on 300 studies facilitating EDC since the turn of the century; 130 of these have since been locked. While early EDC studies...
Explore here
Media Coverage
Global partnership enable big pharma to streamline drug development and refocus their efforts on core competencies. Read more of this story.
Read more
Press Release
RESEARCH TRIANGLE PARK, N.C. – March 11, 2009 – Quintiles Transnational Corp. reached a milestone as its central laboratory in Buenos Aires, Argentina, was accredited recently by the College of American Pathologists (CAP), giving Quintiles the largest CAP-accredited central laboratory network in the world and setting a standard for patient safety and faster drug...
Read More
Press Release
Quintiles Central Laboratory Services is pleased to announce that its lab in Buenos Aires, Argentina has received accreditation from the College of American Pathologists (CAP), making it the 10th lab in what was already the largest network of CAP accredited labs.“CAP accreditation for our Argentina facility is a very important approval, since it underscores our commitment...
Read More
Video
Since opening in early 2007, our central laboratory in Mumbai has provided the quality, flexibility and speed needed to help run efficient clinical trials. Harmonized with our global network of central labs, we ensure consistent data through uniform instrumentation and standardized SOPs. So you can gain access to patient populations anywhere in India, knowing your data is...
Video
Since 1998 we have partnered with Diagnosticos da America to offer laboratory services in Latin America. Through uniform instrumentation and our global standard operating procedures (SOPs), we provide you with consistent and harmonized data comparable across our network of wholly owned and affiliate labs, making it easier for you to compare your laboratory data across...
Video
With the largest network of wholly owned, CAP-accredited central labs in the industry, we provide you: Consistent and comparable results from region to region, study to study Uniform instrumentation and SOPs Reduced inter-country and inter-continental shipping This means you get reliable and harmonized data, allowing you to make real-time decisions on your study trends.